Exploiting Cameleon Probes to Investigate Organelles Ca2+ Handling

Parvalbumin affects skeletal muscle trophism through modulation of mitochondrial calcium uptake

Parvalbumin (PV) is a cytosolic Ca²⁺-binding protein highly expressed in fast skeletal muscle, contributing to an increased relaxation rate. Moreover, PV is an “atrogene” downregulated in most muscle atrophy conditions. Here, we exploit mice lacking PV to explore the link between the two PV functions. Surprisingly, PV ablation partially counteracts muscle loss after denervation. Furthermore, acute PV downregulation is accompanied by hypertrophy and upregulation by atrophy. PV ablation has a minor impact on sarcoplasmic reticulum but is associated with increased mitochondrial Ca²⁺ uptake, mitochondrial size and number, and contacts with Ca²⁺ release sites. Mitochondrial calcium uniporter (MCU) silencing abolishes the hypertrophic effect of PV ablation, suggesting that mitochondrial Ca²⁺ uptake is required for hypertrophy. In turn, an increase of mitochondrial Ca²⁺ is required to enhance expression of the pro-hypertrophy gene PGC-1α4, whose silencing blocks hypertrophy due to PV ablation. These results reveal how PV links cytosolic Ca²⁺ control to mitochondrial adaptations, leading to muscle mass regulation.

•

PV is downregulated during skeletal muscle atrophy, and its levels affect trophism

•

Skeletal muscle mitochondria undergo remodeling in PV knockout mice

•

Mitochondria increase cytosolic Ca²⁺ buffer capacity in PV knockout skeletal muscles

•

Increased mitochondrial Ca²⁺ triggers the PGC-1α4 pathway, inducing muscle growth

Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2

Alzheimer's disease (AD) is the most common form of dementia. Even though most AD cases are sporadic, a small percentage is familial due to autosomal dominant mutations in amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) genes. AD mutations contribute to the generation of toxic amyloid β (Aβ) peptides and the formation of cerebral plaques, leading to the formulation of the amyloid cascade hypothesis for AD pathogenesis. Many drugs have been developed to inhibit this pathway but all these approaches currently failed, raising the need to find additional pathogenic mechanisms. Alterations in cellular calcium (Ca2+) signaling have also been reported as causative of neurodegeneration. Interestingly, Aβ peptides, mutated presenilin-1 (PS1), and presenilin-2 (PS2) variously lead to modifications in Ca2+ homeostasis. In this contribution, we focus on PS2, summarizing how AD-linked PS2 mutants alter multiple Ca2+ pathways and the functional consequences of this Ca2+ dysregulation in AD pathogenesis.